Objective. The Surgical Apgar Score (SAS) is a validated postoperative complication prediction model. The purpose of this study was to investigate the utility of the SAS in a diverse head and neck cancer population and to compare it with a recently developed modified SAS (mSAS) that accounts for intraoperative transfusion.
O riginally proposed in 2007 by Gawande et al, 1 the Surgical Apgar Score (SAS) is a 10-point scoring system based on intraoperative values for lowest mean arterial pressure, lowest heart rate, and estimated blood loss (EBL; Table 1 ). The goal of this score was to provide an objective gauge of patient condition postoperatively to guide clinical practice. The initial study focused on a cohort of patients undergoing general and vascular surgery, which found that patients with poor scores (4) were 16 times more likely to experience a major complication than patients with the highest scores (9 or 10). 2 The SAS has since been validated in a number of surgical specialties. [2] [3] [4] [5] [6] [7] Although a recent study examined its use among patients undergoing major head and neck reconstruction with a fibular free flap, 8 the SAS has not been evaluated in a population undergoing more general head and neck cancer surgery.
However, the SAS has been called into question with regard to its accuracy. EBL is notably more subjective than mean arterial pressure and heart rate. Visual estimation of surgical blood loss was reported to be inaccurate in multiple studies. [9] [10] [11] Ejaz et al 12 recently sought to solve this problem by replacing the subjective and often inaccurate EBL parameter with intraoperative blood transfusion. They showed that patients receiving an intraoperative transfusion had a significantly increased risk of postoperative morbidity than patients not receiving a transfusion. 13 This negative impact to postoperative morbidity was therefore incorporated into a modified SAS (mSAS) by assigning zero points in the EBL category if the patient received an intraoperative transfusion. Their study obtained added predictive value by including intraoperative transfusion for patients undergoing major gastrointestinal surgery.
The purpose of this study was therefore to investigate the utility of the original SAS and to compare this with the recently developed mSAS in a general head and neck cancer population. We hypothesized the SAS would prove useful in predicting postoperative complications and that the mSAS would improve its predictive abilities.
Methods
After University of Alabama at Birmingham Institutional Review Board approval, a retrospective chart review was undertaken. Patients were identified and selected per the Current Procedural Terminology codes listed in Appendix Table 1 (available in the online version of the article) for the period between April 1, 2012, and March 31, 2015, at the University of Alabama at Birmingham Medical Center (Birmingham, Alabama). The flowchart in Figure 1 illustrates the path to our final sample of 713 patients. Major inclusion criteria included age 18 years, complete intraoperative data parameters needed to compute the SAS and mSAS, and a primary diagnosis of head and neck cancer. There were five 30-day mortalities that were excluded from final analysis. Due to the small number, predictive associations for mortality were not meaningful.
Electronic medical records (EMRs) of included patients were queried for demographics, including age, sex, race, smoking status, body mass index (BMI), and American Society of Anesthesiologists (ASA) status. Intraoperative data regarding mean arterial pressure (mm Hg), heart rate (per minute), EBL (mL), and use of blood products were gathered from anesthesia records. Vital signs are routinely recorded every 15 seconds during an operative case, and the data are stored in a Microsoft SQL Server database. This database was queried with Microsoft SQL Server Management Studio.
Calculation of the original SAS and mSAS was completed as described by Gawande et al 1 and Ejaz et al, 12 respectively. Similar to the original SAS, mean arterial pressure and heart rate were translated into the same point system. However, unique to the mSAS is an EBL score of zero assigned to every patient who received an intraoperative transfusion, regardless of the reported EBL. Intraoperative transfusions were defined as any transfusion that started while the patient was in the operating room.
Operation time was recorded as the time elapsed in hours from the documented time of incision to the documented time of closure. Finally, 30-day postoperative morbidity and mortality events and hospital length of stay were manually extracted from the EMR. Morbidities were gathered per the common postoperative head and neck complications listed in the study by Ettinger et al. 8 Based on their criteria, all medical complications were recorded as major, with the exception of renal insufficiency, urinary tract infection, and postoperative blood transfusions. Surgical complications requiring a return to the operating room were considered Occurrence of pathologic bradydysrhythmia-including sinus arrest, atrioventricular block or dissociation, junctional or ventricular escape rhythms, and asystole-also receives 0 points for lowest heart rate. major, and those not requiring a return to the operating room were classified as minor.
Statistical Analysis
Demographics and clinical characteristics were then summarized with descriptive statistics: mean and SD for continuous variables, frequency and percentage for categorical variables, and 95% CI for all variables. Simple linear regression was used to examine the associations of the SAS and mSAS with demographics and clinical measurements. The primary outcome was 30-day postoperative morbidity composed of 3 categories: none, minor, and major. To identify demographic and clinical variables that were associated with 30-day postoperative morbidity, a chi-square (or Fisher's exact) test and analysis of variance were used. The predictive ability of the SAS and mSAS for 30-day morbidity (minor or major vs none) was quantified with a receiver operating characteristic curve with calculated area under the curve. Multivariable analyses were conducted to evaluate the associations of the SAS and mSAS with 30-day morbidity separately, while adjusting for potential confounding variables. Since the proportional odds assumption was not satisfied (P \ .0001) for fitting an ordinal logistic regression, a multinomial logistic regression was chosen as the appropriate multivariable model. To avoid overfitting the model, only variables with P \ .20 in the bivariate analysis were selected for inclusion into the final model.
14 Multicollinearity was assessed with Spearman correlation matrix and variance inflation factor. 15 The inclusion criteria for the multivariable model were based on clinical relevance, correlation r \ 0.40, and variance inflation factor \5. [16] [17] [18] A P value \.05 was considered statistically significant in 2-tailed statistical tests. All analyses were conducted with SAS 9.4 software (SAS Institute, Cary, North Carolina). The receiver operating characteristic plots were created with R 3.3.0. 19 Table 2 presents summary statistics for the patient characteristics. The sample of 713 patients with head and neck cancer was 70.4% male and 29.6% female, with an average age of 59.7 years. The majority of patients were white (81.4%) and current nonsmokers (80.2%), and with a mean BMI of 26.4; 79.4% of patients were classified as ASA class III. The most common tumor type was noncutaneous squamous cell carcinoma (79%), followed by thyroid (9.8%), salivary (5.1%), cutaneous squamous cell carcinoma (4.5%), and other (1.7%). The mean operative time and length of stay were 6.3 hours and 5.4 days, respectively. Thirty-three percent of the patient population had a minor or major 30-day postoperative morbidity. Mean SAS and mSAS were 6.35 and 6.15, respectively. Figure 2 shows the distributions of minor and major 30-day postoperative morbidity by the SAS and mSAS. The mSAS is strongest at predicting morbidity in the 0-4 score range.
Results
The results of simple linear regression (Table 3) showed that race, BMI, ASA status, morbidity score, length of stay, and operation time were significantly associated with either the SAS or the mSAS (P \ .05). African Americans appeared to have a lower SAS (or mSAS) than white and other races. Patients without any sign of morbidity exhibited a higher SAS or mSAS than those with a minor or major morbidity (P \ .0001). The SAS or mSAS increases as ASA status downgrades. Likewise, length of stay and operation time both showed an inverse relationship with the SAS or mSAS. BMI increases as the SAS or mSAS increases, although not substantially.
The bivariate analysis ( Table 4 ) revealed significant associations with morbidity for BMI, ASA status, length of stay, operation time, the SAS, and the mSAS (P \ .05). The areas under the curve for the SAS and mSAS were 0.73 and 0.75, respectively, indicating that the mSAS has better predictive power than the SAS (Figure 3 ). In the multivariable analysis evaluating the SAS and mSAS (Tables 5 and 6), BMI and operation time were significant independent predictors of morbidity (P \ .01) in both models after adjusting for confounding variables. However, only the mSAS remained significant after the adjustment (P = .03), suggesting a greater capability than the SAS to independently predict morbidity. For every point increase in the mSAS, patients are 21% less likely to experience major versus no morbidity given that the other variables in the model are held constant. Similarly, the odds of developing a minor versus no morbidity also decrease by 16% for every additional point in the mSAS. In other words, the likelihood of having a major or minor morbidity versus none is lower for patients with a high mSAS. For operation time, longer duration substantially increases the likelihood of acquiring a minor or major morbidity. Interestingly, the likelihood of a major or minor morbidity is reduced for patients with an elevated BMI.
Discussion
Modeled after the Apgar obstetric scoring system, the SAS is meant to serve as an objective assessment of a patient's condition postoperatively and assist in clinical communication. In addition to the surgical team's evaluation of a patient's clinical status, a quantitative adjunct such as the SAS has the potential to identify those at risk for postoperative morbidity early on and assist with decision making regarding postoperative management. Comorbidities play an undeniable part in a patient's risk for complications, but a study by Regenbogen et al found that even after detailed adjustment for comorbidity and procedure-specific risk factors, the 3 factors composing the SAS remained predictors of the risk for a major complication. 20 Furthermore, it is simple enough that it can even be measured continuously during a surgical case and can provide immediate detection of changes in a patient's accumulating risk of postoperative complications. 21 Given our current medical climate, prognostic indicators that can lead to better patient outcomes and lowered medical costs are valuable. Just as the ASA status lends a certain connotation to a patient's preoperative health, the SAS can provide information regarding one's postoperative condition.
As with other oncologic specialties, the need for a postoperative prognostic indicator in head and neck cancer is great. Aging individuals are undergoing lengthy procedures, as surgery is still the most effective ablative treatment for head and neck cancer irrespective of age. 22 Here we demonstrate the utility of both the original SAS and the mSAS in predicting 30-day postoperative morbidity in a large cohort of patients with head and neck cancer and various primary tumor types. This is in contrast to previous studies of head and neck cases that did not identify a statistically significant relationship with the SAS. 8, 23 In concordance with the study by Ejaz et al, our study found the mSAS to be an even more robust predictor of postoperative morbidity. Because of perceived collinearity with EBL, transfusion was originally omitted from the SAS. The inclusion of intraoperative transfusion, however, appears to strengthen the prognostic value of the original SAS. The decision to transfuse appears to be independent of the EBL and is based on multiple factors, such as hemodynamic stability, pre-and intraoperative hemoglobin levels, and end-organ perfusion. 12 Perhaps it is this variety of factors that culminate in the decision to transfuse intraoperatively that contributes to the improved predictability of the mSAS.
Efforts have been made at applying the SAS across surgical subspecialties, as evidenced by the volume of literature on the topic that has been created since its original proposition. Reynolds et al 23 reviewed the SAS and mortality of .100,000 surgical procedures in all subspecialties and found that the magnitude varied by subspecialty. Higher odds ratios were seen in some subspecialties, suggesting that the score may not be as useful for them. Our results showed a significant inverse relationship between operative time and Apgar score. This variable is applicable to all subspecialties and could be a useful modification to the SAS to broaden its utility across all surgical subspecialties.
There are limitations to our study, including the retrospective design and other possible confounding variables that were not taken into account. Cancer staging was not part of our analysis, as these data were not available for all patients, but it should certainly be a consideration for future studies since later-stage malignancies may predispose to a higher postoperative complication rate. We also acknowledge that errors can be made in the retrieval and recording of data in the EMR. The majority of our population was recorded in the EMR to be current nonsmokers, but given that the majority cancer diagnosis was squamous cell carcinoma, this seems unlikely. We also included all types of primary head and neck cancers and acknowledge that these cancers can behave differently from one other and have different clinical courses and risk factors. However, these data reflect a larger population and can therefore make our findings more generalizable. Last, we chose to exclude the low number of mortalities from our study, as this would not alter the statistics; thus, we cannot comment specifically on mortality prediction. Future prospective studies with postoperative treatment algorithms are needed to determine if using these scores to guide postoperative care results in lower morbidity and mortality. The score's greatest utility may lie in determining which patients would be better served with immediate postoperative care in the intensive care unit, and this is one suggestion for future studies.
Conclusion
The SAS serves as a useful metric for risk stratification of patients with head and neck cancer. With the inclusion of intraoperative transfusion, the mSAS demonstrates superior utility in predicting those at risk for postoperative complications. A strong inverse relationship exists between operative time and length of stay and the mSAS.
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